Full Year 2024 DocMorris AG Earnings Call Transcript
Key Points
- DocMorris AG (XSWX:DOCM) achieved significant milestones in 2024, including a fivefold increase in new RX customers since the introduction of Carlink.
- The company reached profitability in its non-RX business, reflecting successful execution of its breakeven program.
- Overall revenue increased by 7%, with contributions from all business segments.
- Teleclinic doubled its revenues, demonstrating strong performance and attractive profitability metrics.
- Effective cash management resulted in a cash balance of CHF95 million at the end of 2024.
- The EBTA came in lower than last year, reflecting additional marketing expenses for the ERX business.
- There was a slight decline in basket size, order frequency, and repeat order rate, attributed to the influx of new customers.
- The company is unable to provide a detailed short and mid-term guidance due to being in a capital raise mode.
- Marketing expenses increased significantly, impacting the adjusted EBTA.
- The company faces challenges in gaining new customers, partially due to cautious marketing spendings in the first quarter.
Yeah, thank you very much and, good morning to everybody to today's conference call. The full year results 24 will be presented by Daniel West, our new CFO, and myself.
We will share insights and updates across all segments and provide a comprehensive overview of our business performance.
So we will start with a business update followed by a financial update and conclude with our outlook thereafter. We are looking forward to answering your questions.
Let us start with the highlights of last year.
In 2024, we achieved significant milestones again.
Since the introduction of Carlink in April 24, there has been a fivefold increase in new RX customers.
These new customers show significantly improved KPIs compared to our former PRX customers.
We are very pleased to announce that in 2024 we reached profitability with our non RX business.
It reflects our strategic efforts and the successful execution of the breakeven program over the last few years.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
